Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium

References

• Lee J-M, Greenleaf AL. CTD kinase large subunit is encoded by CTK1, a gene required for normal growth of Saccharomyces cerevisiae. Gene Expr. 1991;1:149–167.
   PubMed Web of Science ®Google Scholar
• Sterner DE, Lee JM, Hardin SE, et al. The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex. Mol Cell Biol. 1995;15:5716–5724.
   PubMed Web of Science ®Google Scholar
• Wood A, Shilatifard A. Bur1/Bur2 and the Ctk complex in yeast: the split personality of mammalian P-TEFb. Cell Cycle. 2006;5:1066–1068.
   PubMed Web of Science ®Google Scholar
• Liu J, Kipreos ET. Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. Mol Biol Evol. 2000;17:1061–1074.
   PubMed Web of Science ®Google Scholar
• Guo Z, Stiller JW. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs. BMC Genomics. 2004;5:69.
   PubMed Web of Science ®Google Scholar
• Phatnani HP, Greenleaf AL. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006;20:2922–2936.
   PubMed Web of Science ®Google Scholar
• Ko TK, Kelly E, Pines J. CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. J Cell Sci. 2001;114:2591–2603.
   PubMed Web of Science ®Google Scholar
• Chen -H-H, Wang Y-C, Fann M-J. Identification and characterization of the CDK12/Cyclin L1 complex involved in alternative splicing regulation. Mol Cell Biol. 2006;26:2736–2745.
   PubMed Web of Science ®Google Scholar
• Marqués F, Moreau JL, Peaucellier G, et al. A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. Biochem Biophys Res Commun. 2000;279:832–837.
   PubMed Web of Science ®Google Scholar
• Even Y, Durieux S, Escande M-L, et al. CDC2L5, a Cdk-like kinase with RS domain, interacts with the ASF/SF2-associated protein p32 and affects splicing in vivo. J Cell Biochem. 2006;99:890–904.
   PubMed Web of Science ®Google Scholar
• Chen -H-H, Wong Y-H, Geneviere A-M, et al. CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. Biochem Biophys Res Commun. 2007;354:735–740.
   PubMed Web of Science ®Google Scholar
• Bartkowiak B, Liu P, Phatnani HP, et al. CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 2010;24:2303–2316.
   PubMed Web of Science ®Google Scholar
• Blazek D, Kohoutek J, Bartholomeeusen K, et al. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 2011;25:2158–2172.
   PubMed Web of Science ®Google Scholar
• Dai Q, Lei T, Zhao C, et al. Cyclin K-containing kinase complexes maintain self-renewal in murine embryonic stem cells. J Biol Chem. 2012;287:25344–25352.
   PubMed Web of Science ®Google Scholar
• Cheng SWG, Kuzyk MA, Moradian A, et al. Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the c-terminal domain of RNA polymerase II. Mol Cell Biol. 2012;32:4691–4704.
   PubMed Web of Science ®Google Scholar
• Bowman EA, Bowman CR, Ahn JH, et al. Phosphorylation of RNA polymerase II is independent of P-TEFb in the C. elegans germline. Development. 2013;140:3703–3713.
   PubMed Web of Science ®Google Scholar
• Heidemann M, Hintermair C, Voß K, et al. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim Biophys Acta. 2012;1829:55–62.
   PubMed Web of Science ®Google Scholar
• Popova T, Manié E, Boeva V, et al. Ovarian cancers harboring inactivating mutations in CDK12 display a distinct genomic instability pattern characterized by large tandem duplications. Cancer Res. 2016;76:1882–1891.
   PubMed Web of Science ®Google Scholar
• Wu Y-M, Cieślik M, Lonigro RJ, et al. Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer. Cell. 2018;173:1770–1782.e14.
   PubMed Web of Science ®Google Scholar
• Li M, Phatnani HP, Guan Z, et al. Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1. Proc Natl Acad Sci USA. 2005;102:17636–17641.
   PubMed Web of Science ®Google Scholar
• Aymard F, Bugler B, Schmidt CK, et al. Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks. Nat Struct Mol Biol. 2014;21:366–374.
   PubMed Web of Science ®Google Scholar
• Kizer KO, Phatnani HP, Shibata Y, et al. A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation. Mol Cell Biol. 2005;25:3305–3316.
   PubMed Web of Science ®Google Scholar
• Bøsken CA, Farnung L, Hintermair C, et al. The structure and substrate specificity of human Cdk12/Cyclin K. Nat Commun. 2014;5:3505 EP.
   Web of Science ®Google Scholar
• Dixon-Clarke SE, Elkins JM, Cheng S-WG, et al. Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding. Sci Rep. 2015;5:17122.
   PubMed Web of Science ®Google Scholar
• Greifenberg AK, Hönig D, Pilarova K, et al. Structural and functional analysis of the Cdk13/Cyclin K Complex. Cell Rep. 2016;14:320–331.
   PubMed Web of Science ®Google Scholar
• Bartkowiak B, Greenleaf AL. Expression, purification, and identification of associated proteins of the full-length hCDK12/CyclinK complex. J Biol Chem. 2015;290:1786–1795.
   PubMed Web of Science ®Google Scholar
• Jones JC, Phatnani HP, Haystead TA, et al. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J Biol Chem. 2004;279:24957–24964.
   PubMed Web of Science ®Google Scholar
• Bensaude O. Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity? Transcription. 2014;2:103–108.
   Google Scholar
• Chao SH, Fujinaga K, Marion JE, et al. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem. 2000;275:28345–28348.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski N, Zhang T, Rahl PB, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 2014;511:616–620.
   PubMed Web of Science ®Google Scholar
• Zhang T, Kwiatkowski N, Olson CM, et al. Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. Nat Chem Biol. 2016;12:876–884.
   PubMed Web of Science ®Google Scholar
• Johannes JW, Denz CR, Su N, et al. Structure-based design of selective noncovalent CDK12 inhibitors. ChemMedChem. 2018;13:231–235.
   PubMed Web of Science ®Google Scholar
• Blethrow J, Zhang C, Shokat KM, et al. Design and use of analog-sensitive protein kinases. Curr Protoc Mol Biol. 2004;66:18.11.1–18.11.19.
   Google Scholar
• Bartkowiak B, Yan C, Greenleaf AL. Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas. Biochim Biophys Acta. 2015;1849:1179–1187.
   PubMed Web of Science ®Google Scholar
• Davidson L, Muniz L, West S. 3ʹ end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells. Genes Dev. 2014;28:342–356.
   PubMed Web of Science ®Google Scholar
• Eifler TT, Shao W, Bartholomeeusen K, et al. Cyclin-dependent kinase 12 increases 3ʹ end processing of growth factor-induced c-FOS transcripts. Mol Cell Biol. 2015;35:468–478.
   PubMed Web of Science ®Google Scholar
• Liang K, Gao X, Gilmore JM, et al. Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing. Mol Cell Biol. 2015;35:928–938.
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615.
   PubMed Web of Science ®Google Scholar
• Carter SL, Cibulskis K, Helman E, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413–421.
   PubMed Web of Science ®Google Scholar
• Paculova H, Kohoutek J. The emerging roles of CDK12 in tumorigenesis. Cell Div. 2017;12:7.
   PubMed Web of Science ®Google Scholar
• Chilà R, Guffanti F, Damia G. Role and therapeutic potential of CDK12 in human cancers. Cancer Treat Rev. 2016;50:83–88.
   PubMed Web of Science ®Google Scholar
• Dong X, Chen G, Cai Z, et al. CDK13 RNA over-editing mediated by ADAR1 associates with poor prognosis of hepatocellular carcinoma patients. Cell Physiol Biochem. 2018;47:2602–2612.
   PubMed Web of Science ®Google Scholar
• Paulsen MT, Veloso A, Prasad J, et al. Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA. Methods. 2014;67:45–54.
   PubMed Web of Science ®Google Scholar
• Andrade-Lima LC, Veloso A, Paulsen MT, et al. DNA repair and recovery of RNA synthesis following exposure to ultraviolet light are delayed in long genes. Nucleic Acids Res. 2015;43:2744–2756.
   PubMed Web of Science ®Google Scholar
• Kaida D, Berg MG, Younis I, et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature. 2010;468:664–668.
   PubMed Web of Science ®Google Scholar
• Phatnani HP, Jones JC, Greenleaf AL. Expanding the functional repertoire of CTD kinase I and RNA polymerase II: novel phosphoCTD-associating proteins in the yeast proteome. Biochemistry. 2004;43:15702–15719.
   PubMed Web of Science ®Google Scholar
• Bentley DL. The mRNA assembly line: transcription and processing machines in the same factory. Curr Opin Cell Biol. 2002;14:336–342.
   PubMed Web of Science ®Google Scholar
• Carty SM, Greenleaf AL. Hyperphosphorylated C-terminal repeat domain-associating proteins in the nuclear proteome link transcription to DNA/chromatin modification and RNA processing. Mol Cell Proteomics. 2002;1:598–610.
   PubMed Web of Science ®Google Scholar
• Kanagaraj R, Huehn D, Mackellar A, et al. RECQ5 helicase associates with the C-terminal repeat domain of RNA polymerase II during productive elongation phase of transcription. Nucleic Acids Res. 2010;38:8131–8140.
   PubMed Web of Science ®Google Scholar
• Winsor TS, Bartkowiak B, Bennett CB, et al. A DNA damage response system associated with the phosphoCTD of elongating RNA polymerase II. PLoS One. 2013;8:e60909.
   PubMed Web of Science ®Google Scholar
• Zhu X, He F, Zeng H, et al. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet. 2014;46:287–293.
   PubMed Web of Science ®Google Scholar